Skip to main content

falbikitug

Generic: Falbikitug

falbikitug: 2 clinical trials tracked.

falbikitug evidence translation

What we can confirm

2 tracked trials

No verified listed developer

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about falbikitug, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence0 indications · 1 study sponsors

Related indications

No linked indication is available.

Clinical Trials (2)

A Phase II, Open-label, Multicentre, Randomised Study of Neoadjuvant and Adjuvant Treatment in Patients With Resectable, Early-stage (II to IIIB) Non-small Cell Lung Cancer (NeoCOAST-2)

NCT05061550·Phase 2·AZN
Recruiting

Primary endpoint: Number of participants with pathological complete response (pCR)

InterventionalRandomizedopen630 targetStarted 2022-04Completion 2030-0550 sites · Belgium, Canada, France, Hungary…AstraZeneca

A Phase II Study to Evaluate the Safety, Pharmacokinetics, and Clinical Activity of AZD0171 in Combination With Durvalumab and Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumours

NCT04999969·Phase 2·AZN
Active, not recruiting

Primary endpoint: Number of Participants With Adverse Events (AEs), Immune Mediated AEs (imAEs) and Serious AEs (SAEs)

Interventionalopen126 targetStarted 2021-12Completion 2026-0634 sites · Canada, South Korea, Spain, United StatesAstraZeneca